MYX THERAPEUTICS

MyX Therapeutics is a provider of medical research and development services intended to offer treatment for various type of asthma diseases. The company develops a drug delivery technology that covalently links to mucous membranes and it's delivery vehicle is able to deliver pharmaceuticals reliably due to the covalent linkage, enabling medical practitioners to obtain market sector differentiating novel products for delivery of ophthalmic, sublingual, intranasal, vaginal and IR of drug.